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Hypertension causes worldwide an estimated 9.4 million deaths per year, more than half of the estimated 17 mil-
lion cardiovascular deaths.1 Hypertension firmly remains the 
strongest modifiable cardiovascular risk factor. For diagnosis 
and management of hypertension, several guidelines2,3 rec-
ommended thresholds for blood pressure that are applicable 
irrespective of sex or age. A recent analysis4 of the relation-
ship between adverse cardiovascular outcomes and systolic 
blood pressure demonstrated that the risk increased more 
in women than in men, thereby revealing a largely unused 
potential for cardiovascular prevention in women. The 2014 
Evidence-Based Guideline for the Management of High 
Blood Pressure in Adult proposed 150 mm Hg instead of 
140 mm Hg as operational threshold to start and adjust drug 
treatment in older patients with hypertension.5 Similarly, the 
2013 European guidelines proposed higher thresholds for the 
elderly (≥80 years) than for younger adults.6 This recommen-
dations5 revived the controversy on whether blood pressure 
thresholds should differ according to age or not.7 We used the 
International Database of Home Blood Pressure in Relation to 
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Cardiovascular Outcome8 to investigate whether sex and age 
should be accounted for in deriving outcome-driven blood 
pressure thresholds. To ascertain consistency in our conclu-
sions, we applied a 2-pronged approach. First, we derived 
thresholds for the home blood pressure (HBP) that yielded 
risks similar to long established thresholds for the conventional 
blood pressure (CBP). Next, we determined thresholds for the 
CBP yielding risks similar to generally accepted thresholds for 
the HBP. To address the research question at hand, we stratified 
our analyses by sex and age.
Methods
Study Participants
The International Database of Home Blood Pressure in Relation to 
Cardiovascular Outcome databases include studies involving a ran-
dom population sample with longitudinal follow-up of fatal and non-
fatal cardiovascular outcomes.8 At the time of writing this report, we 
collected data from 7 prospective studies (8912 participants).9–15 For 
the present analysis, we discarded 2159 people (Figure) because data 
on cause-specific mortality were unavailable13 or because the study 
participants were referred patients instead of a population sample.12 
In the 5 population cohorts, included in the present analysis, the par-
ticipation rate weighted for sample size was 57.3%.16 Of the remain-
ing 6753 participants, we excluded 1735 because <2 measurements 
were available to characterize the CBP (n=266) or HBP (n=18) or 
because participants were on antihypertensive drug treatment at base-
line (n=1465). Therefore, the number of participants statistically ana-
lyzed totaled 5018, comprising 2010 inhabitants of Ohasama, Japan,11 
1605 Finns representing a nationwide sample,10 476 inhabitants of the 
Tsurugaya district, Sendai, Japan,14 356 inhabitants of Montevideo, 
Uruguay,9 and 571 inhabitants of Didima, Greece.15 Characteristics 
of the participants excluded from the analysis seem in Table S1 in the 
online-only Data Supplement. All studies received ethical approval 
and participants gave written informed consent.
Blood Pressure Measurement
The CBP was measured twice by a standard mercury sphygmoma-
nometer or a validated automated device using the appropriate cuff 
size after the participants had rested for ≥2 minutes.8 For analysis, 
these 2 readings were averaged. We categorized the CBP according 
current guidelines.2,3,6 The established diagnostic levels were 120, 
130, 140, and 160 mm Hg systolic and 80, 85, 90, and 100 mm Hg 
diastolic. HBP was measured with validated automated devices, 
using the appropriate cuff size, after 2 to 5 minutes rest. For analysis, 
all HBP readings of each participant were averaged. In our analysis, 
we considered levels of 125, 130, and 135 mm Hg systolic and 80 and 
85 mm Hg diastolic as thresholds for the HBP.
Other Measurements
In all cohorts, questionnaires were used to obtain detailed informa-
tion on each participant’s medical history, intake of medications, and 
current smoking habits. Body mass index was body weight in kilo-
grams divided by height in meters squared. Previous cardiovascular 
disease included cardiac and cerebrovascular disorders and periph-
eral vascular disease. Serum total cholesterol and blood glucose were 
determined by automated enzymatic methods on venous blood sam-
ples. Diabetes mellitus was a fasting or random blood glucose level of 
7.0 mmol/L (126 mg/dL) or 11.1 mmol/L (200 mg/dL) or higher, use 
of antidiabetic drugs, a self-reported diagnosis, or diabetes mellitus 
documented in practice or hospital records.17
Ascertainment of Events
We ascertained vital status and incidence of fatal and nonfatal dis-
eases from the appropriate sources in each country, as described in 
detail in a previous publication.8 Fatal and nonfatal stroke did not 
include transient ischemic attacks. Coronary events encompassed 
death because of ischemic heart disease, sudden death, nonfatal myo-
cardial infarction, and surgical and percutaneous coronary revascu-
larization. Cardiac events comprised coronary end points, fatal and 
nonfatal heart failure, pacemaker implantation, and other cardiac 
deaths. The composite cardiovascular end point included cardiovas-
cular mortality and cerebrovascular and cardiac end points. In all 
outcome analyses, we only considered the first event per participant.
Statistical Methods
For database management and statistical analysis, we used SAS soft-
ware, version 9.3 (SAS Institute, Cary, NC). We compared means and 
proportions by the large-sample z test and by the χ2 statistic, respec-
tively. Statistical significance was an α-level of <0.05 on 2-sided tests. 
We interpolated missing values of body mass index (n=382) and serum 
cholesterol (n=133) from the regression slope on age after stratifica-
tion for cohort and sex. In participants with unknown smoking habits 
(n=19), we set the design variable to the cohort- and sex-specific mean 
of the codes (0, 1). As described elsewhere,8 while stratifying for sex and 
10-year age groups, we extrapolated serum cholesterol for the Didima 
participants15 from the levels observed in the ATTICA study,18,19 which 
included a population sample examined at the same time (2001–2002) 
and in the same geographical area as the Didima participants.
We calculated hazard ratios using Cox regression while adjust-
ing for cohort, sex, age, body mass index, smoking, serum choles-
terol, and history of cardiovascular disease and diabetes mellitus. We 
checked the proportional hazards assumption by the Kolmogorov-
type supremum test. From the multivariable-adjusted Cox models, 
we extrapolated the 10-year risk of end points associated with given 
levels of CBP or HBP.
As described in detail elsewhere,20,21 we derived thresholds yield-
ing equivalent 10-year risks of an end point for the HBP (result) from 
the CBP (reference) and vice versa in 4 steps. First, we computed 
the 10-year incidence rates of end points from the reference blood 
pressure. Second, we computed the 10-year incidence rates of an 
end point associated with the blood pressure under investigation for 
blood pressure levels ranging from the 5th to 95th percentile using 
steps of 0.1 mm Hg. In a third step, we selected blood pressure levels 
of the blood pressure measurement under investigation (result) that 
were associated with similar 10-year risks as given levels of the refer-
ence measurement. Next, we calculated the bootstrap distribution22 
of the so-obtained new diagnostic thresholds by randomly resam-
pling the study population 1000× with replacement, using the PROC 
SURVEYSELECT procedure, as implemented in the SAS package. 
For each new sample, we repeated the first 3 steps. We accounted 
for tied event times, caused by resampling with replacement, by the 
TIESEXACT option in the PROC PHREG procedure. Finally, we 
calculated the bootstrap point estimates and 95% confidence inter-
vals of the new thresholds as the mean±(1.96×SE) of the bootstrap 
distribution.22
 
2843  Women
2175  Men
2896  <60 Years   
2122  ≥60 Years
8912 in Database
6753 Eligible
Not Eligible
Referred Patients 
5018 Analyzed
Incomplete Blood Pressure Data 
on Antihypertensive Drug Treatment
1735 Excluded
426
1733 Incomplete Outcome Data
284
1451
2159 
Figure. Flow chart of study participants.
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Results
Baseline Characteristics of Participants
The whole study population (n=5018) included 2843 (56.7%) 
women, 2175 (43.3%) White Europeans, 356 (7.1%) South 
Americans of White European descent, and 2486 (49.5%) 
Japanese. In the whole cohort, age averaged 57.1±13.6 years, 
ranging from 18.5 to 97.0 years. Blood pressure on conven-
tional measurement averaged 129.3±17.4 mm Hg systolic 
and 77.9±11.5 mm Hg diastolic; for the self-measured blood 
pressure at home, these levels were 123.9±17.2 mm Hg and 
74.9±9.8 mm Hg, respectively. At baseline, 1624 (32.4%) par-
ticipants had hypertension.
Table 1 provides the baseline characteristics of the study pop-
ulation by sex and age group (<60 versus ≥60 years). All sex 
differences were significant (P≤0.028) with the exception of age 
(P=0.24). All of the differences between age groups were signif-
icant (P<0.001) except for diastolic blood pressure on conven-
tional measurement (P=0.12) and serum cholesterol (P=0.63). 
Table S2 lists the characteristics of participants by cohort.
Incidence of End Points
In the overall study population, median follow-up was 8.3 years 
(5th–95th percentile interval, 4.7–16.8 years). During 46 651 
person-years of follow-up, 522 participants died (11.2 per 1000 
person-years), 158 of a cardiovascular cause (3.4 per 1000 per-
son-years). A fatal or nonfatal cardiovascular event occurred 
in 414 participants (8.9 per 1000 person-years), including 194 
cardiac events (4.2 per 1000 person-years) and 225 strokes (4.8 
per 1000 person-years). Women compared with men had consis-
tently lower risk of a cardiovascular end point (Tables 2 and 3), 
a cardiac event (Tables S3 and S4), or stroke (Tables S5 and S6).
Thresholds for HBP Derived From CBP
Table 2 lists the thresholds of the HBP that yielded multi-
variable-adjusted 10-year risks of a cardiovascular end point 
similar to those associated with the established reference lev-
els on CBP measurement. None of the newly derived HBP 
thresholds differed between sexes (P≥0.24) or between age 
groups (P≥0.12) with the exception of borderline significant 
age-group differences in the HBP thresholds between derived 
from CBP levels of 140 mm Hg systolic (younger versus 
older participants, 128.4 versus 132.7 mm Hg; P=0.031) and 
80 mm Hg diastolic (younger versus older participants, 75.8 
versus 77.7 mm Hg; P=0.044). The sex differences (women 
minus men) between the HBP thresholds ranged from –4.6 to 
3.1 mm Hg systolic and from –4.3 to –0.2 mm Hg diastolic; 
the corresponding age-group differences (young minus old) 
ranged from –1.9 to –6.7 mm Hg systolic and from –1.9 to 0 
mm Hg diastolic (Table 3). Sensitivity analyses based on car-
diac events (Table S3) or stroke (Table S5) produced consis-
tent results without significant differences in the thresholds for 
the HBP between sexes (P≥0.10) and age groups (P≥0.11), 
with the exception of the home thresholds for stroke risk cor-
responding with a conventional systolic blood pressure of 130 
mm Hg in younger versus older participants (119.1 versus 
128.8 mm Hg; P=0.019; Table S5).
Thresholds for CBP Derived From HBP
Table 4 lists the thresholds of the CBP that yielded multi-
variable-adjusted 10-year risks of a cardiovascular end point 
similar to those associated with given levels of the HBP. None 
of the derived thresholds for the CBP differed between sexes 
(P≥0.33) or between age groups (P≥0.08). The sex differences 
Table 1. Baseline Characteristics Stratified by Sex and Age
Characteristics
Sex Age
Women (n=2843) Men (n=2175) <60 y (n=2896) ≥60 y (n=2122)
No. with characteristics (%)
  Asian 1480 (52.1) 1006 (46.3) 1088 (37.6) 1398 (65.9)
  Hypertension 832 (29.3) 792 (36.4) 713 (24.6) 911 (42.9)
  Diabetes mellitus 157 (5.5) 170 (7.8) 124 (4.3) 203 (9.6)
  Current smoking 317 (11.2) 831 (38.2) 796 (27.5) 352 (16.6)
  Previous cardiovascular 
disease
129 (4.5) 200 (9.2) 73 (2.5) 256 (12.1)
Mean characteristic (±SD)
  Age, y 56.9±13.6 57.4±13.4 47.7±8.7 70.0±6.7
  Body mass index, kg/m2 25.0±4.3 25.3±3.8 25.4±4.1 24.8±4.1
  Serum cholesterol, mmol/L 5.48±1.02 5.36±1.11 5.44±1.07 5.42±1.04
  Conventional blood pressure, mm Hg
   Systolic blood pressure 129.0±20.5 133.3±18.4 125.7±17.7 138.0±20.1
   Diastolic blood pressure 76.0±11.3 80.4±11.3 77.7±11.6 78.2±11.4
  Home blood pressure, mm Hg
   Systolic blood pressure 121.4±17.7 127.2±15.9 118.4±14.8 131.5±17.4
   Diastolic blood pressure 72.9±9.6 77.5±9.5 74.1±10.1 76.1±9.3
Hypertension was a conventional blood pressure of ≥140 mm Hg systolic or ≥90 mm Hg diastolic. None of the participants was on antihypertensive drug 
treatment. Diabetes mellitus was a fasting or random blood glucose concentration of ≥7.0 mmol/L or ≥11.1 mmol/L, use of antidiabetic drugs, a self-reported 
diagnosis, or diabetes mellitus documented in practice or hospital records. All sex differences were significant (P≤0.028) except for age (P=0.24). All age 
differences were significant (P<0.001) except for serum cholesterol (P=0.63) and diastolic blood pressure on conventional measurement (P=0.12).
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(women minus men) between the CBP thresholds ranged from 
–0.7 to 3.6 mm Hg systolic and from 1.9 to 2.1 mm Hg dia-
stolic; the corresponding age-group differences (young minus 
old) ranged from 6.1 to 8.4 mm Hg systolic and from 0.7 to 1.7 
mm Hg diastolic. Sensitivity analyses based on cardiac events 
(Table S4) or stroke (Table S6) produced consistent results 
without significant differences in the thresholds for the HBP 
between sexes (P≥0.19) and age groups (P≥0.052).
Discussion
In a previous International Database of Home Blood Pressure 
in Relation to Cardiovascular Outcome publication,21 we deter-
mined HBP thresholds, which yielded 10-year cardiovascular 
risks similar to those associated with prehypertension stages 
1 (120/80 mm Hg) and 2 (130/85 mm Hg) and with hyper-
tension stages 1 (140/90 mm Hg) and 2 (160/100 mm Hg). 
In these analyses, we adjusted for cohort.21 In our current 
study, we used the same bootstrap methods,21 but we stratified 
our analyses by sex and age to investigate whether outcome-
driven thresholds for the self-measured blood pressure might 
be different in women versus men and in younger versus older 
subjects. In the derivation of sex- and age-specific thresholds 
for the HBP from established cutoff limits of the CBP, the 
key findings can be summarized as follows. First, all of the 
sex differences in the HBP thresholds, irrespective of the 
level of the CBP from which they were derived, were small 
and not statistically significant. On average (Table 3), these 
thresholds tended to be 0.2 mm Hg systolic and 2.3 mm Hg 
diastolic lower in women than men. Second, most of the age 
differences in the HBP thresholds, as derived from the CBP, 
were nonsignificant except for those corresponding with a 
CBP of 140 mm Hg systolic (4.3 mm Hg higher in elderly) and 
Table 3. Home Blood Pressure Differences According to Sex and Age Yielding 10-Year Risks of a Cardiovascular End 
Point Equivalent to Given Levels of the Conventional Blood Pressure
Conventional Blood Pressure 
Level Used as Reference, mm Hg
Sex Difference (Women Minus Men) Age Difference (Younger Minus Older)
Estimate (95% CI) P Value Estimate (95% CI) P Value
Systolic
  120 3.1 (–5.7 to 11.9) 0.24 –1.9 (–11.9 to 7.8) 0.35
  130 1.2 (–2.2 to 4.7) 0.24 –3.1 (–8.3 to 2.0) 0.12
  140 –0.6 (–5.8 to 4.5) 0.40 –4.3 (–8.8 to 0.2) 0.03
  160 –4.6 (–19.7 to 10.4) 0.27 –6.7 (–19.8 to 6.4) 0.15
Diastolic
  80 –0.2 (–5.3 to 4.8) 0.46 –1.9 (–4.1 to 0.3) 0.04
  85 –1.5 (–9.6 to 6.5) 0.35 –1.4 (–7.1 to 4.2) 0.31
  90 –3.0 (–13.9 to 7.9) 0.29 –0.9 (–9.0 to 7.3) 0.41
  100 –4.3 (–16.8 to 8.2) 0.25 0.0 (–7.5 to 7.5) 0.50
Point estimates used to calculate sex and age-group differences are given in Table 2. Significance levels for the differences between strata were 
calculated using a large sample z test. CI indicates confidence interval.
Table 2. Home Blood Pressure Levels Yielding 10-Year Risks of a Cardiovascular End Point Equivalent to Given Levels of the 
Conventional Blood Pressure
Conventional 
Blood Pressure 
Level Used as 
Reference, mm Hg
Sex Age
Women (n=2843) Men (n=2175) <60 y (n=2896) ≥60 y (n=2122)
Risk, %
Home Blood  
Pressure, mm Hg Risk, %
Home Blood  
Pressure, mm Hg Risk, %
Home Blood  
Pressure, mm Hg Risk, %
Home Blood  
Pressure, mm Hg
Systolic
  120 3.3 117.7 (112.1–123.3) 7.6 114.6 (107.8–121.3) 2.1 115.1 (110.4–119.8) 13.1 117.1 (108.4–125.8)
  130 3.6 123.9 (122.5–125.3) 8.8 122.7 (119.5–125.8) 2.5 121.8 (120.6–122.9) 14.6 124.9 (119.9–129.9)
  140 4.1 130.1 (125.2–135.1) 10.1 130.8 (129.4–132.1) 3.0 128.4 (124.3–132.5) 16.3 132.7 (130.8–134.6)
  160 5.1 142.2 (129.3–155.1) 13.6 146.8 (139.1–154.6) 4.3 141.5 (130.2–152.8) 20.2 148.2 (141.5–154.9)
Diastolic
  80 3.8 76.5 (71.8–81.2) 9.1 76.7 (75.0–78.5) 2.5 75.8 (74.2–77.5) 16.6 77.7 (76.3–79.1)
  85 4.1 79.7 (71.8–87.6) 10.1 81.2 (79.6–82.8) 2.9 80.3 (76.3–84.3) 17.9 81.7 (77.7–85.7)
  90 4.4 82.6 (72.4–92.8) 11.3 85.6 (81.9–89.3) 3.3 84.6 (78.7–90.5) 19.2 85.4 (79.9–91.0)
  100 5.1 87.1 (74.9–99.2) 14.0 91.4 (88.6–94.1) 4.4 90.5 (84.6–96.4) 22.2 90.5 (85.8–95.2)
Risk refers to the 10-y risk of a cardiovascular end point standardized to the mean distribution of cohort, sex (only for analyses stratified by age), age, body mass 
index, smoking, cholesterol, previous cardiovascular disease, and diabetes mellitus in the whole study population. In addition, for analyses stratified by age, the risk 
estimates were standardized to average age within the 2 age groups. Point estimates and 95% confidence intervals were obtained from the bootstrap distribution 
of 1000 random samples of the study population with replacement (for further details, see Methods). There were no differences in the derived home blood pressure 
thresholds between sexes (P≥0.24) or between age groups (P≥0.12) with the exception of 140 mm Hg (P=0.031) and 80 mm Hg (P=0.044) in age strata.
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80 mm Hg diastolic (1.9 mm Hg higher in elderly). However, 
there was a consistent trend (Table 3) for the HBP thresholds 
to be on average 4.0 mm Hg systolic and 1.1 mm Hg diastolic 
higher in older compared with younger participants.
Methods to derive threshold values for the self-measured 
blood pressure at home evolved over time.23 Initially, pro-
posals for reference values for the self-measured blood 
pressure at home relied mainly on the comparison of the 
distributions of the HBP between people who were normo-
tensive or had hypertension on CBP measurement.24,25 The 
International Database of Home Blood Pressure in Relation 
to Cardiovascular Outcome consortium recently proposed the 
first outcome-driven thresholds.21 Rounded thresholds cor-
responding to prehypertension stages 1 and 2 and hyperten-
sion stages 1 and 2 amounted to 120/75, 125/80, 130/85, and 
145/90 mm Hg, respectively.21 Current guidelines recommend 
a threshold of 135 mm Hg systolic and 85 mm Hg diastolic 
as the dividing line between normotension and hypertension 
based on the self-measured blood pressure at home and pro-
pose that these cutoff limits are applicable in both sexes and 
across the age range. Our current analysis confirms this view-
point with regard to the application of the proposed thresh-
olds in both sexes. However, outcome-driven thresholds for 
the HBP might be slightly higher above age 60 years than in 
younger individuals, but this age difference is probably negli-
gible in clinical practice. Moreover, the relationship between 
cardiovascular risk and blood pressure is continuous, and 
thresholds only guide clinicians in diagnosing hypertension 
and in starting and adjusting antihypertensive drug treatment.
In our current study, we could not fully replicate the results 
of a previous report based on ambulatory blood pressure 
measurement.4 To analyze sex-specific relative and absolute 
risks associated with blood pressure, we performed CBP and 
24-hour ambulatory blood pressure measurements in 9357 
subjects (mean age, 52.8 years; 47% women) recruited from 
11 populations.4 As in our current study, women compared 
with men were at lower risk. The hazard ratios for death and 
all cardiovascular events were 0.66 and 0.62, respectively 
(P<0.001).4 However, the relationship of all cardiovascular 
events with 24-hour systolic blood pressure and the relation-
ships of total mortality and all cardiovascular, cerebrovascu-
lar, and cardiac events with nighttime systolic blood pressure 
were significantly steeper (P≤0.045) in women than in men.4 
Consequently, per a 1-SD decrease, the proportion of poten-
tially preventable events was higher in women than in men 
for all cardiovascular events (35.9% versus 24.2%) in relation 
Table 4. Conventional Blood Pressure Levels Yielding 10-Year Risks of a Cardiovascular End Point Equivalent to Given Levels of the 
Home Blood Pressure
Home Blood 
Pressure 
Level Used as 
Reference, mm Hg
Sex Age
Women (n=2843) Men (n=2175) <60 y (n=2896) ≥60 y (n=2122)
Risk, %
Conventional Blood  
Pressure, mm Hg Risk, %
Conventional Blood  
Pressure, mm Hg Risk, %
Conventional Blood  
Pressure, mm Hg Risk, %
Conventional Blood  
Pressure, mm Hg
Systolic
  125 3.7 131.9 (125.8–138.1) 9.1 132.6 (129.7–135.5) 2.8 135.4 (129.4–141.4) 14.6 129.3 (122.3–136.4)
  130 4.1 140.8 (129.1–152.5) 10.0 139.1 (137.6–140.7) 3.2 143.6 (133.8–153.4) 15.6 136.1 (132.5–139.9)
  135 4.5 149.2 (133.5–165.0) 11.0 145.7 (141.7–149.7) 3.6 151.5 (138.9–164.0) 16.8 143.0 (140.5–145.6)
Diastolic
  80 4.1 85.8 (73.1–98.5) 9.9 83.7 (82.6–84.8) 2.9 85.2 (80.6–89.8) 17.4 83.4 (79.2–87.6)
  85 4.6 91.7 (76.6–106.8) 11.2 89.9 (85.6–94.1) 3.4 91.0 (84.2–97.8) 19.2 90.3 (82.9–97.6)
Risk refers to the 10-y risk of a cardiovascular end point standardized to the mean distribution of cohort, sex (only for analyses stratified by age), age, body mass 
index, smoking, cholesterol, previous cardiovascular disease, and diabetes mellitus in the whole study population. In addition, for analyses stratified by age, the risk 
estimates were standardized to average age within the 2 age groups. Point estimates and 95% confidence intervals were obtained from the bootstrap distribution of 
1000 random samples of the study population with replacement (for further details, see Methods). There were no differences in the derived conventional blood pressure 
thresholds between sexes (P≥0.33) or age (P≥0.08) strata.
Table 5. Conventional Blood Pressure Differences According to Sex and Age Yielding 10-Year Risks of a Cardiovascular 
End Point Equivalent to Given Levels of the Home Blood Pressure
Hone Blood Pressure Level Used 
as Reference, mm Hg
Sex Difference (Women Minus Men) Age Difference (Younger Minus Older)
Estimate (95% CI) P Value Estimate (95% CI) P Value
Systolic
  125 –0.7 (–7.4 to 6.1) 0.42 6.1 (–3.1 to 15.3) 0.09
  130 1.7 (–10.1 to 13.5) 0.39 7.4 (–3.1 to 17.9) 0.08
  135 3.6 (–12.6 to 19.8) 0.33 8.4 (–4.4 to 21.2) 0.09
Diastolic
  80 2.1 (–10.7 to 14.8) 0.37 1.7 (–4.5 to 8.0) 0.29
  85 1.9 (–13.8 to 17.5) 0.40 0.7 (–9.3 to 10.8) 0.44
Point estimates used to calculate sex and age-group differences are given in Table 4. Significance levels for the differences between strata were 
calculated using a large sample z test. CI indicates confidence interval.
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to 24-hour systolic blood pressure and for all-cause mortal-
ity (23.1% versus 12.3%) and cardiovascular (35.1% versus 
19.4%), cerebrovascular (38.3% versus 25.9%), and cardiac 
(31.0% versus 16.0%) events in relation to systolic nighttime 
blood pressure.4 Using the self-measured HBP in our present 
study, we could not replicate the aforementioned observations.4 
We suspect that the underlying reason is that the ambulatory 
blood pressure is more informative than the self-measured 
HBP because 24-hour recordings include the nighttime blood 
pressure, which was the main drivers of our previous findings4 
and which from a prognostic viewpoint is most accurate.26,27
The evidence that the self-measured blood pressure at home 
is superior to the CBP in risk stratification and in the predic-
tion of cardiovascular complications is overwhelming.10,23 We, 
therefore, also derived sex- and age-specific thresholds for the 
CBP from established cutoff limits of the HBP. The key find-
ing was that the sex and age differences between thresholds 
for the CBP derived from the HBP were all nonsignificant. 
However, there was a consistent trend (Table 5) for the conven-
tional systolic thresholds to be on average 7.3 mm Hg higher 
in younger than they were in older participants. Our current 
observations highlight the uncertainty about target blood pres-
sure levels to be achieved by drug treatment as summarized 
in recent US recommendations.5 This guideline affirmed 
that there is strong evidence to support treating patients with 
hypertension aged ≥60 years to a blood pressure goal on con-
ventional measurement of <150/90 mm Hg and patients with 
hypertension 30 through 59 years of age to a diastolic goal 
of <90 mm Hg. Furthermore, the guideline stated that there is 
insufficient evidence in patients with hypertension <60 years 
for a systolic goal or in those <30 years for a diastolic goal 
and, therefore, recommended a target blood pressure on con-
ventional measurement of <140/90 mm Hg for those groups 
based on expert opinion. The threshold of hypertension for the 
self-measured HBP is 135/85 mm Hg. As shown in Table 4, 
the corresponding conventional thresholds ranged from 143.0 
to 151.5 mm Hg systolic and from 89.8 to 91.7 mm Hg, with 
no significant differences between strata.
Our current study must be interpreted within the context of 
its potential limitations. First, the anthropometric characteris-
tics, the time of recruitment, and the number of HBP measure-
ments differed between cohorts. Second, serum cholesterol 
was unavailable for the Didima cohort and was extrapolated 
from the ATTICA study. However, the Didima cohort con-
tributed only 10% to the whole study population. Moreover, 
excluding serum cholesterol from the Cox models did not 
materially alter our current results. Third, the CBP was the 
average of only 2 readings obtained at a single examination. 
Fourth, the participation rate weighted for the contribution 
of each cohort averaged 57.3%. Finally, our analysis rested 
on 5 population-based cohorts with an overrepresentation of 
Asians and whites and might, therefore, not be representative 
for other ethnic groups, in particular blacks.
Perspectives
From a clinical viewpoint, our current results based on out-
come-driven criteria support contemporary guidelines2,3,6 that 
propose single blood pressure thresholds that can be indis-
criminately applied in both sexes and across the age range. 
Furthermore, our observations highlight that the evidence 
underpinning recommendations about the blood pressure lev-
els at which to start antihypertensive drug treatment or target 
levels to be achieved on treatment remains insufficient. The 
relationship between cardiovascular complications and blood 
pressure is linear without threshold above which the risk sud-
denly increases.28 In all age groups and in both sexes, the risk 
increases from levels on conventional measurement as low 
as 115 mm Hg systolic and 75 mm Hg diastolic.28 Evidence-
based recommendations should meet the clinical needs of 
most patients but will never be a substitute for clinical judg-
ment. Clinicians must carefully consider and incorporate the 
clinical characteristics and circumstances of each individual 
patient in their decision-making process.5
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What Is New?
•	This is the first population-based study to derive outcome-driven thresh-
old for the home (HBP) and conventional (CBP) blood pressure stratified 
by sex and age. We used multivariable-adjusted Cox regression and a 
bootstrap procedure to determine HBP levels yielding 10-year cardiovas-
cular risks similar to those associated with established systolic/diastolic 
thresholds on CBP measurement and vice versa.
What Is Relevant?
•	The sex differences between HBP thresholds derived from CBP and be-
tween CBP thresholds derived from HBP were all nonsignificant.
•	The age differences between HBP thresholds derived from CBP and be-
tween CBP thresholds derived from HBP were nonsignificant, except for 
HBP thresholds derived from CBP levels of 140 mm Hg systolic and 80 
mm Hg diastolic.
Summary
Our findings based on outcome-driven criteria support contempo-
rary guidelines that propose single blood pressure thresholds that 
can be indiscriminately applied in both sexes and across the age 
range.
Novelty and Significance
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Table S1. Participation Rate and Characteristics of 1753 Excluded Individuals by Cohort  
Characteristics Ohasama  Finn-Home  Tsurugaya  Didima  Montevideo  All Cohorts  
Catchment area 
Iwate prefec-
ture, Japan 
Nationwide  
Finland 
Sendai, Japan 
Argolida of  
Peloponnesus, 
Greece 
Uruguay …  
No. in IDHOCO database 2777 2075 836 665 400 6753  
Excluded  767 470  360  94  44  1735  
No. with characteristics (%)       
Women 404 (52.7)  265 (56.4)  209 (58.1)  61 (64.9)  24 (54.6)  963 (55.5)  
Diabetes mellitus  85 (11.1)  63 (13.4)  70 (19.4)  12 (12.8)  7 (15.9)  237 (13.7)  
Current smoking 179 (23.3)  68 (14.5)  35 (10.0)  10 (10.8)  4 (9.1)  296 (17.2)  
Previous cardiovascular disease 116 (15.1)  117 (24.9)  83 (23.1)  35 (37.2)  7 (15.9)  358 (20.6)  
Mean characteristic (SD) 
Age, y  61.5 (13.3) 61.0 (8.2)  75.6 (4.7)  70.5 (9.1)  58.6 (11.1)  64.7 (12.0)  
Body mass index, kg/m2  23.8 (3.3)  29.3 (4.7)  24.3 (3.4)  29.6 (4.6)  27.4 (4.6)  25.9 (4.7)  
Serum cholesterol (mmol/L) 5.08 (0.99)  6.10 (1.15)  5.29 (0.83)  …  5.84 (0.92)  5.50 (1.10)  
Conventional measurement (mm Hg)   
Systolic blood pressure 139.5 (18.2)  146.7 (19.0)  148.3 (20.2)  146.5 (22.1)  142.5 (25.4)  144.5 (19.8)  
Diastolic blood pressure 78.1 (12.3)  86.7 (9.9)  84.4 (10.9)  78.9 (11.5)  89.0 (14.6)  82.7 (11.9)  
Home measurement (mm Hg)   
Systolic blood pressure 129.1 (14.3)  139.6 (17.1)  146.0 (19.1)  144.9 (19.1)  127.8 (17.0)  136.3 (18.0) 
Diastolic blood pressure 77.0 (9.3)  84.2 (8.3)  78.7 (10.7)  78.6 (10.1)  80.4 (10.2)  79.5 (9.9)  
Diabetes mellitus was a fasting or random blood glucose concentration ≥7.0mmol/L or ≥11.1 mmol/L, use of antidiabetic drugs, a self-reported di-
agnosis, or diabetes documented in practice or hospital records.  Conventional measurement, smoking status, and body mass index were unavail-
able in 261, 11, and 143 participants, respectively. Serum cholesterol was not available in Didima cohort.   
  
Table S2. Baseline Characteristics of Participants by Cohort  
Characteristics Ohasama  Finn-Home  Tsurugaya  Didima  Montevideo  All Cohorts  
Number of participants 2010 1605 476 571 356 5018 
No. with characteristics (%)       
Women 1226 (61.0) 848 (52.8) 254 (53.4) 326 (57.1) 189 (53.1) 2843 (56.6) 
Hypertension  507 (25.2) 676 (42.1) 257 (54.0) 138 (24.2) 46 (12.9) 1624 (32.4) 
Diabetes mellitus  167 (8.3) 67 (4.2) 54 (11.3) 18 (3.2) 21 (5.9) 327 (6.5) 
Current smoking 408 (20.3) 414 (25.8) 67 (14.3) 159 (27.9) 100 (28.1) 1148 (22.9) 
Previous cardiovascular disease 95 (4.7) 134 (8.4) 49 (10.3) 24 (4.2) 27 (7.6) 329 (6.6) 
Mean characteristic (SD) 
Age, y  58.3 (12.3) 56.0 (8.3) 75.2 (4.5) 51.6 (17.2) 39.9 (11.2) 57.1 (13.6) 
Body mass index, kg/m2  23.4 (3.0) 26.9 (4.3) 23.5 (3.3) 26.6 (4.1) 25.9 (4.5) 25.1 (4.1) 
Serum cholesterol (mmol/L) 4.98 (0.86) 6.15 (1.10) 5.29 (0.87) 5.10 (0.44) 5.50 (1.04) 5.43 (1.06) 
Conventional measurement (mm Hg)   
Systolic blood pressure 129.3 (17.4) 134.7 (19.8) 143.2 (20.5) 124.2 (19.5) 117.4 (16.8) 129.3 (17.4) 
Diastolic blood pressure 73.7 (10.9) 82.9 (10.5) 82.8 (10.6) 76.0 (10.9) 76.3 (10.5) 77.9 (11.5) 
Home measurement (mm Hg)   
Systolic blood pressure 121.3 (14.0) 127.0 (18.2) 136.0 (19.4) 121.0 (17.9) 113.3 (12.9) 123.9 (17.2) 
Diastolic blood pressure 72.6 (9.2) 79.1 (9.2) 76.2 (9.9) 72.8 (8.7) 70.2 (10.2) 74.9 (9.8) 
Hypertension was a conventional blood pressure of ≥140 mmHg systolic or ≥90 mmHg diastolic. None of the participants was on antihypertensive 
drug treatment. Diabetes mellitus was a fasting or random blood glucose concentration ≥7.0mmol/L or ≥11.1 mmol/L, use of antidiabetic drugs, a 
self-reported diagnosis, or diabetes documented in practice or hospital records. Between-cohort differences were significant (P<0.0001).  
  
Table S3. Home Blood Pressure Levels Yielding 10-Year Risks of a Cardiac Endpoint Equivalent to Given Levels of the Conven-
tional Blood Pressure  
Conventional 
blood pressure 
level used as  
reference  
(mm Hg)  
Sex  Age  
Women (n=2843)   Men (n=2175)   <60 Years (n=2896)   ≥60 Years (n=2122)  
Risk  
(%)  
Home Blood Pressure 
 (mm Hg)  
 
Risk 
(%)  
Home Blood Pressure 
(mm Hg)  
 
Risk  
(%)  
Home Blood Pressure 
(mm Hg)  
 
Risk 
(%)  
Home Blood Pressure 
(mm Hg)  
Systolic, mm Hg              
120  1.2  117.3 (93.7–141.0)  5.5  112.1 (99.4–124.7)  1.7  118.8 (114.8–122.8)  8.0  107.8 (75.5–140.1)  
130  1.3  121.9 (110.7–133.1)  6.2  121.9 (114.8–129.0)  1.9  122.8 (120.2–125.5)  9.1  114.5 (84.8–144.2)  
140  1.4  129.3 (106.5–152.0)  7.1  132.9 (126.1–139.7)  2.1  126.9 (120.3–133.5)  10.4  129.0 (112.8–145.2)  
160  1.7  138.9 (106.7–171.1)  9.3  150.3 (138.4–162.1)  2.7  134.9 (120.0–149.9)  13.4  149.9 (118.1–181.7)  
Diastolic, mm Hg              
80  1.4  76.4 (67.6–85.2)  6.5  77.1 (71.5–82.7)  1.8  76.2 (74.5–78.0)  10.6  77.0 (68.0–85.9)  
85  1.5  78.6 (62.4–94.8)  6.8  79.6 (71.2–88.0)  2.0  78.8 (74.6–83.0)  11.2  78.3 (57.7–99.0)  
90  1.6  80.8 (60.9–100.6)  7.1  81.9 (68.8–95.1)  2.2  81.3 (73.9–88.6)  11.7  78.8 (54.1–103.5)  
100  1.8  82.6 (59.1–106.1)  7.8  84.7 (66.7–102.7)  2.7  85.7 (73.5–97.9)  12.5  79.0 (51.5–106.5)  
Risk refers to the 10-year risk of a cardiac endpoint standardized to the mean distribution of cohort, sex (only for analyses stratified by age), age, body mass index, smok-
ing, cholesterol, previous cardiovascular disease, and diabetes mellitus in the whole study population. In addition, for analyses stratified by age, the risk estimates were 
standardized to average age within the 2 age groups. Point estimates and 95% confidence intervals were obtained from the bootstrap distribution of 1000 random samples 
of the study population with replacement (for further details, see Methods). There were no differences in the derived home blood pressure thresholds between sexes 
(P≥0.25) or age (P≥0.20) strata.  
  
Table S4. Conventional Blood Pressure Levels Yielding 10-Year Risks of a Cardiac Endpoint Equivalent to Given Levels of the 
Home Blood Pressure  
Home blood 
pressure level  
used as  
reference  
(mm Hg)  
Sex  Age  
Women (n=2843)   Men (n=2175)   <60 Years (n=2896)   ≥60 Years (n=2122)  
Risk  
(%)  
Conventional  
Blood Pressure  
 (mm Hg)   
Risk 
(%)  
Conventional  
Blood Pressure  
(mm Hg)   
Risk  
(%)  
Conventional  
Blood Pressure  
(mm Hg)   
Risk 
(%)  
Conventional  
Blood Pressure  
(mm Hg)  
Systolic, mm Hg              
125  1.3  133.1 (117.6–148.6)  6.4  132.1 (126.9–137.3)  2.0  135.0 (114.8–155.1)  10.1  137.9 (130.2–145.5)  
130  1.4  140.4 (114.7–166.2)  6.9  137.9 (133.3–142.4)  2.2  146.2 (119.6–172.8)  10.4  140.2 (135.9–144.6)  
135  1.5  145.2 (114.6–175.8)  7.4  143.4 (134.6–152.3)  2.6  154.7 (126.0–183.4)  10.8  142.5 (138.3–146.7)  
Diastolic, mm Hg              
80  1.4  80.5 (61.3–99.6)  6.8  83.3 (70.4–96.3)  2.1  86.4 (72.0–100.8)  10.7  79.8 (66.3–93.3)  
85  1.5  83.1 (59.2–106.9)  7.4  87.7 (66.1–109.2)  2.5  92.5 (74.7–110.2)  10.7  80.4 (60.4–100.4)  
Risk refers to the 10-year risk of a cardiac endpoint standardized to the mean distribution of cohort, sex (only for analyses stratified by age), age, body mass index, smok-
ing, cholesterol, previous cardiovascular disease, and diabetes mellitus in the whole study population. In addition, for analyses stratified by age, the risk estimates were 
standardized to average age within the 2 age groups. Point estimates and 95% confidence intervals were obtained from the bootstrap distribution of 1000 random samples 
of the study population with replacement (for further details, see Methods). There were no differences in the derived thresholds for the conventional blood pressure be-
tween sexes (P≥0.38) or age (P≥0.19) strata.   
  
Table S5. Home Blood Pressure Levels Yielding 10-Year Risks of Stroke Equivalent to Given Levels of the Conventional Blood 
Pressure  
Conventional 
blood pressure 
level used as  
reference  
(mm Hg)  
Sex  Age  
Women (n=2843)   Men (n=2175)   <60 Years (n=2896)   ≥60 Years (n=2122)  
Risk  
(%)  
Home Blood Pressure 
 (mm Hg)  
 
Risk 
(%)  
Home Blood Pressure 
(mm Hg)  
 
Risk  
(%)  
Home Blood Pressure 
(mm Hg)  
 
Risk 
(%)  
Home Blood Pressure 
(mm Hg)  
Systolic, mm Hg              
120  2.0  118.6 (113.8–123.5)  3.1  115.4 (106.9–124.0)  0.8 109.9 (88.4–131.5) 6.7 123.9 (117.7–130.3) 
130  2.2  124.0 (122.6–125.5)  3.6  122.8 (118.4–127.2)  1.0 119.1 (110.6–127.7) 7.5 128.8 (125.4–132.0)  
140  2.6  129.4 (125.4–133.4)  4.2  130.2 (128.3–132.1)  1.2 131.0 (109.2–152.8) 8.3 133.7 (132.2–135.2) 
160  3.4  140.1 (128.4–151.9)  5.7  144.8 (135.9–153.7)  2.0 146.2 (119.1–173.2) 10.3 143.4 (137.2–149.6) 
Diastolic, mm Hg              
80  2.4  76.1 (72.4–79.9)  3.8  77.5 (74.5–80.5)  1.1 76.3 (65.2–87.3) 8.5 78.1 (76.8–79.4) 
85  2.6  78.9 (72.4–85.3)  4.4  82.9 (79.5–86.2)  1.2 82.6 (65.7–99.4) 9.4 81.1 (78.3–83.8) 
90  2.9  81.5 (72.9–90.1)  5.1  87.8 (83.1–92.4)  1.5 86.4 (67.7–105.0) 10.3 84.0 (79.4–88.5) 
100  3.5  86.0 (74.9–97.1)  6.9  91.8 (88.8–94.8)  2.1 88.3 (69.0–107.7) 12.5 89.0 (83.0–95.0) 
Risk refers to the 10-year risk of a stroke standardized to the mean distribution of cohort, sex (only for analyses stratified by age), age, body mass index, smoking, choles-
terol, previous cardiovascular disease, and diabetes mellitus in the whole study population. In addition, for analyses stratified by age, the risk estimates were standardized 
to average age within the 2 age groups. Point estimates and 95% confidence intervals were obtained from the bootstrap distribution of 1000 random samples of the study 
population with replacement (for further details, see Methods). There were no differences in the derived home blood pressure thresholds between sexes (P≥0.10) or age 
(P≥0.11) strata, except for the home thresholds corresponding with a conventional systolic blood pressure of 130 mm Hg in younger vs. older participants (P=0.019).     
  
Table S6. Conventional Blood Pressure Levels Yielding 10-Year Risks of Stroke Equivalent to Given Levels of the Home Blood 
Pressure  
Home blood 
pressure level  
used as  
reference  
(mm Hg)  
Sex  Age  
Women (n=2843)   Men (n=2175)   <60 Years (n=2896)   ≥60 Years (n=2122)  
Risk  
(%)  
Conventional 
Blood Pressure  
 (mm Hg)   
Risk 
(%)  
Conventional  
Blood Pressure  
(mm Hg)   
Risk  
(%)  
Conventional  
Blood Pressure  
(mm Hg)   
Risk 
(%)  
Conventional  
Blood Pressure  
(mm Hg)  
Systolic, mm Hg              
125  2.3  132.2 (124.1–140.3)  3.7  132.4 (127.6–137.1)  1.1  134.8 (125.5–144.0)  6.9  120.6 (106.2–135.0)  
130  2.6  142.7 (129.3–156.1)  4.2  139.9 (137.2–142.6)  1.2  139.3 (124.7–153.9)  7.7  131.5 (122.2–140.9)  
135  3.0  152.0 (136.4–167.6)  4.6  147.4 (140.6–154.2)  1.4  143.6 (124.5–162.7)  8.6  143.0 (135.4–150.0)  
Diastolic, mm Hg              
80  2.7  87.7 (74.7–100.6)  4.0  82.3 (80.9–83.7)  1.1  81.5 (74.0–88.9)  9.1  83.7 (77.6–89.7)  
85  3.2  93.6 (80.2–107.0)  4.7  87.5 (84.0–91.0)  1.3  84.3 (72.7–95.8)  10.7  92.1 (83.7–100.6)  
Risk refers to the 10-year risk of a stroke standardized to the mean distribution of cohort, sex (only for analyses stratified by age), age, body mass index, smoking, choles-
terol, previous cardiovascular disease, and diabetes mellitus in the whole study population. In addition, for analyses stratified by age, the risk estimates were standardized 
to average age within the 2 age groups. Point estimates and 95% confidence intervals were obtained from the bootstrap distribution of 1000 random samples of the study 
population with replacement (for further details, see Methods). There were no differences in the derived thresholds for the conventional blood pressure between sexes 
(P≥0.19) or age (P≥0.052) strata.    
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